Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testosterone is crucial for development, growth, and various body functions in mammals.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Androgen use may increase the risk of stroke, but more research is needed.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Spironolactone plus finasteride works better for treating hirsutism.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.